<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161362">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01799395</url>
  </required_header>
  <id_info>
    <org_study_id>13002-Trisolini</org_study_id>
    <nct_id>NCT01799395</nct_id>
  </id_info>
  <brief_title>Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer</brief_title>
  <official_title>Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maggiore Bellaria Hospital, Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maggiore Bellaria Hospital, Bologna</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer may cause central airway obstruction through several different mechanisms
      (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis).

      The aim of the present study is to determine the prevalence at the time of diagnosis, the
      incidence at 1 year from the diagnosis, and the predictors of central airway obstruction
      associated with advanced lung cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Incidence of central airway obstruction</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The incidence will be measured over a 12 month period after diagnosis (or over the life span from diagnosis to death in patients who die before 1 year from the diagnosis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictor variables associated with the presence/occurrence of central airway obstruction</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of central airway obstruction</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>The prevalence of central airway obstruction will be evaluated at the time of diagnosis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung Cancer</arm_group_label>
    <description>All patients with advanced lung cancer candidate for chemotherapy or chemotherapy + radiation therapy will be enrolled and followed-up for 1 year clinically and radiologically (Chest CT) to verify whether or not central airway obstruction is present at the time of diagnosis or occurs in the year following diagnosis (or in the life span from diagnosis and death in patients who die before 1 year of diagnosis). Furthermore, predictor variables possibly associated with central airway obstruction will be studied.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with advanced lung cancer undergoing treatment and follow-up at the Oncology
        Units of the Azienda USL di Bologna (government structure that manages several public
        hospitals that &quot;cover&quot; a 800.000 inhabitants area)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Advanced lung cancer with indication for chemotherapy or chemotherapy + radiation
             therapy

        Exclusion Criteria:

          -  Age &lt; 18 year

          -  Pregnancy

          -  Refusal to sign informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rocco Trisolini, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maggiore Bellaria Hospital, Bologna, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rocco Trisolini, M.D.</last_name>
    <phone>0039-051-6478802</phone>
    <email>rocco.trisolini@ausl.bologna.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bentivoglio Hospital</name>
      <address>
        <city>Bentivoglio</city>
        <state>Emilia Romagna</state>
        <zip>40010</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vida Pajetta, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bellaria Hospital</name>
      <address>
        <city>Bologna</city>
        <state>Emilia Romagna</state>
        <zip>40100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giovanna Cavallo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Di Battista, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maggiore Hospital</name>
      <address>
        <city>Bologna</city>
        <state>Emilia Romagna</state>
        <zip>4013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rocco Trisolini, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Patelli, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Budrio Hospital</name>
      <address>
        <city>Budrio</city>
        <state>Emilia Romagna</state>
        <zip>40054</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vida Pajetta, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SS Salvatore Hospital</name>
      <address>
        <city>San Giovanni in Persiceto</city>
        <state>Emilia Romagna</state>
        <zip>40017</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vida Pajetta, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 27, 2013</lastchanged_date>
  <firstreceived_date>February 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maggiore Bellaria Hospital, Bologna</investigator_affiliation>
    <investigator_full_name>Rocco Trisolini</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Airway Obstruction</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
